Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Philip

Showing results (481-490 of 521) with videos related to

Pageof 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancerRyuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Oncogene|June 24, 2021
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancerJingyuan Wang, Joanne Xiu, Yasmine Baca, et al.
JAMA Oncology|January 26, 2023
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon CancerEn Cheng, Qian Shi, Anthony F Shields, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Journal of Surgical Oncology|March 14, 2020
Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinomaMatthew K Stein, Forrest W Williard, Joanne Xiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic AdenocarcinomaPhilip A Philip, Ibrahim Azar, Joanne Xiu, et al.
The Oncologist|August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT studyErkut H Borazanci, Nathan Bahary, Vincent Chung, et al.
Pageof 53

Showing results (481-490 of 521) with videos related to

Sort By:
Pageof 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancerRyuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Oncogene|June 24, 2021
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancerJingyuan Wang, Joanne Xiu, Yasmine Baca, et al.
JAMA Oncology|January 26, 2023
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon CancerEn Cheng, Qian Shi, Anthony F Shields, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Journal of Surgical Oncology|March 14, 2020
Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinomaMatthew K Stein, Forrest W Williard, Joanne Xiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic AdenocarcinomaPhilip A Philip, Ibrahim Azar, Joanne Xiu, et al.
The Oncologist|August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT studyErkut H Borazanci, Nathan Bahary, Vincent Chung, et al.
Pageof 53